journal
https://read.qxmd.com/read/38021410/antifungal-resistance-combinations-and-pipeline-oh-my
#21
REVIEW
Kayla R Stover, Brandon K Hawkins, J Myles Keck, Katie E Barber, David A Cretella
Invasive fungal infections are a strong contributor to healthcare costs, morbidity and mortality, especially amongst hospitalized patients. Historically, Candida was responsible for approximately 15% of all nosocomial bloodstream infections. In the past 10 years, the epidemiology of Candida species has altered, with increasing prevalence of resistant species. With rising fungal resistance, especially in Candida spp., the demand for novel antifungal therapies has exponentially increased over the last decade...
2023: Drugs in Context
https://read.qxmd.com/read/38021409/optimization-of-gdmt-for-patients-with-heart-failure-and-reduced-ejection-fraction-can-physiological-and-biological-barriers-explain-the-gaps-in-adherence-to-heart-failure-guidelines
#22
REVIEW
Marilyne Jarjour, Anique Ducharme
Heart failure is a growing epidemic with high mortality rates and recurrent hospital admissions that creates a burden on affected individuals, their caregivers and the whole healthcare system. Throughout the years, many randomized trials have established the effectiveness of several pharmacological therapies and electrophysiological devices to reduce hospitalizations and improve quality of life and survival, mostly for patients with heart failure with reduced ejection fraction (HFrEF). These studies led to the publication of national societies' recommendations to guide clinicians in the management of HFrEF...
2023: Drugs in Context
https://read.qxmd.com/read/38021408/corrigendum-real-world-management-of-abnormal-scarring-using-topical-silicone-gel-expert-consensus-and-case-series-from-the-asian-scars-expert-group
#23
(no author information available yet)
[This corrects the article DOI: 10.7573/dic.2023-4-3.].
2023: Drugs in Context
https://read.qxmd.com/read/37908643/childhood-guttate-psoriasis-an-updated-review
#24
REVIEW
Alexander Kc Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong
BACKGROUND: Guttate psoriasis is common and affects 0.5-2% of individuals in the paediatric age group. This review aims to familiarize physicians with the clinical manifestations, evaluation, diagnosis and proper management of guttate psoriasis. METHODS: A search was conducted in July 2023 in PubMed Clinical Queries using the key term "guttate psoriasis". The search strategy included all observational studies, clinical trials and reviews published within the past 10 years...
2023: Drugs in Context
https://read.qxmd.com/read/37908642/effect-of-xyloglucan-associations-with-gelatin-or-gelose-on-escherichia-coli-derived-lipopolysaccharide-induced-enteritis-in-rats
#25
JOURNAL ARTICLE
Vassilia Theodorou, Catherine Beaufrand, Hélène Eutamene
BACKGROUND: Escherichia coli is the predominant non-pathogenic facultative microbe of the human intestine, although some strains are diarrhoeagenic in humans. E. coli -derived lipopolysaccharide (LPS) induces diarrhoea, intestinal barrier impairment, bacterial translocation and intestinal inflammation. Associations with the mucoprotectant xyloglucan exhibit antidiarrhoeal effects. This study evaluated and compared the effects of xyloglucan in combination with gelatin or gelose (agar-agar) on jejunal permeability and inflammation using an in vivo rat model of E...
2023: Drugs in Context
https://read.qxmd.com/read/37849655/ingredients-of-vicks-vaporub-inhibit-rhinovirus-induced-atp-release
#26
JOURNAL ARTICLE
Rebecca J Stinson, Alyn H Morice, Basir Ahmad, Laura R Sadofsky
BACKGROUND: Over-the-counter therapies, such as Vicks VapoRub, are frequently used in the management of upper respiratory tract infection symptoms. Of these, acute cough is the most bothersome; however, the mechanisms involved have not been fully elucidated. The temperature-sensitive transient receptor potential (TRP) channels, including TRPA1, TRPV1, TRPM8 and TRPV4, are potential candidates. TRPV4 is also thought to be involved in cough through the TRPV4-ATP-P2X3 pathway. Here, we hypothesise that Vicks VapoRub ingredients (VVRIs) modulate the TRP cough channels...
2023: Drugs in Context
https://read.qxmd.com/read/37781168/efficacy-and-safety-of-baricitinib-in-patients-with-alopecia-areata-evidence-to-date
#27
REVIEW
Sofia Faria, Egídio Freitas, Tiago Torres
Alopecia areata (AA) is a chronic, tissue-specific autoimmune disorder, characterized by non-scaring hair loss, with a global prevalence of approximately 2%. Typically, it affects a young population, with initial onset frequently occurring before the age of 30 years. Even though the exact pathogenesis of AA remains unclear, the predominant hypothesis is the breakdown of immune privilege of the hair follicle, resulting in increased self-antigen and major histocompatibility complex expression in the follicular epithelium...
2023: Drugs in Context
https://read.qxmd.com/read/37711731/calcifediol-in-the-management-of-vitamin-d-deficiency-related-skeletal-and-extraskeletal-diseases-overview-and-clinical-cases
#28
REVIEW
Enrique Casado, Ester Costa, Pedro Mezquita-Raya, Rubén Andújar-Espinosa, José Luis Neyro
As well as being essential for musculoskeletal health, vitamin D is involved in numerous other physiological processes. Poor vitamin D status is linked to a wide range of diseases, including cardiovascular disease, autoimmune conditions, pulmonary disorders and upper respiratory tract infections. While optimal target concentrations of serum 25-hydroxyvitamin D (25(OH)D) for health maintenance or therapeutic purposes are still the subject of debate, there is reasonable agreement that serum 25(OH)D levels <50 nmol/L (20 ng/mL) constitute vitamin D deficiency and that severe deficiency states (serum 25(OH)D levels <25-30 nmol/L ≈ 10-12 ng/mL) should be avoided...
2023: Drugs in Context
https://read.qxmd.com/read/37711730/early-experiences-with-edoxaban-for-stroke-prevention-in-atrial-fibrillation-in-the-southeast-asia-region
#29
JOURNAL ARTICLE
Alejandro Bimbo Diaz, Jeremy Chow, Fan Kee Hoo, Kok Wei Koh, Gary Chin Keong Lee, Wee Siong Teo, Narayanaswamy Venketasubramanian, Chun-Chieh Wang, Radhika Mehta
Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinical and real-world studies. We share early clinical experiences with once-daily edoxaban and discuss its evidence-based use in patients with NVAF in Southeast Asia through several cases of patients at high risk, including frail patients, elderly patients with multiple comorbidities and patients with increased bleeding risk...
2023: Drugs in Context
https://read.qxmd.com/read/37664792/tirzepatide-for-type-2-diabetes
#30
REVIEW
Sarah L Anderson, Joel C Marrs
One in ten adults worldwide is living with diabetes, with 95% having type 2 diabetes (T2D). Sustained glycaemic control in people with T2D is difficult to achieve despite recent advances in T2D management with the advent of glucagon-like peptide 1 receptor agonists (GLP1RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2i). Tirzepatide represents a first-in-class agent as a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP1RA to be approved in the USA and Europe for the treatment of T2D. This narrative review intends to list and discuss the glycaemic efficacy, key safety and weight loss outcomes related to the treatment of T2D with tirzepatide...
2023: Drugs in Context
https://read.qxmd.com/read/37664791/precautions-in-the-management-of-opioid-agonist-therapy-from-target-population-characteristics-to-new-formulations-and-post-marketing-monitoring-a-focus-on-the-italian-system
#31
REVIEW
Guido Mannaioni, Fabio Lugoboni
Opioid use disorder (OUD) is a serious medical condition with vast social, health and economic impact. Individuals with OUD are prescribed opioid agonist therapies, such as methadone, levomethadone, buprenorphine or naloxone/buprenorphine, to reduce the risks associated with illegal substance abuse, eventually leading to opioid use abstinence. The OUD population has peculiar frailties, mainly related to the psychiatric sphere, which may jeopardize their therapeutic course. Amongst the possible phenomena that may contribute to treatment failure, opioid agonist therapy misuse and diversion are of utmost importance, leading to serious repercussions for patients as well as for national health systems...
2023: Drugs in Context
https://read.qxmd.com/read/37602358/use-of-immunomodulatory-therapy-as-part-of-comprehensive-treatment-of-non-severe-community-acquired-pneumonia-and-its-long-term-results
#32
JOURNAL ARTICLE
Mikhail P Kostinov, Vilia V Gainitdinova, Svetlana V Kazharova, Anna E Vlasenko, Vflentina B Polishchuk, Kirill V Mashilov
BACKGROUND: This study investigates the efficiency of two different types of immunomodulators for the treatment of non-severe community-acquired pneumonia (CAP) and assesses their long-term effects. METHODS: The study included 55 patients with non-severe CAP. Group 1 (control) received only standard CAP therapy; the other two groups received immunomodulators simultaneously with the standard therapy: bacterial lysate for group 2 and azoximer bromide (AzB) for group 3...
2023: Drugs in Context
https://read.qxmd.com/read/37602357/clinical-experience-with-pemigatinib-for-previously-treated-metastatic-cholangiocarcinoma-practical-considerations-from-clinical-cases
#33
Jonathan Wadsley, Alan Christie, Roopinder Gillmore, Amy Trinh, Rachel Greig
The management of advanced cholangiocarcinoma (CCA) is challenging. In patients with advanced CCA, gemcitabine/cisplatin combination is the standard frontline chemotherapy, with 5-fluorouracil-based regimens preserved for subsequent lines; however, the expected survival is poor. Pemigatinib was approved for locally advanced or metastatic CCA with FGFR2 fusions or rearrangement. Pemigatinib has a manageable safety profile and achieves a durable response. Nearly 50 patients with CCA have been treated with pemigatinib in the United Kingdom...
2023: Drugs in Context
https://read.qxmd.com/read/37602356/meta-insti-metabolic-adverse-events-following-integrase-strand-transfer-inhibitor-administration-in-spontaneous-adverse-event-reports
#34
JOURNAL ARTICLE
Milena M Murray, Lara Fakhouri, Spencer E Harpe
BACKGROUND: Metabolic effects of integrase strand transfer inhibitors (INSTIs) have been reported. The FDA Adverse Event Reporting System (FAERS) is a publicly available database that captures spontaneously reported adverse events. The objective of this study was to evaluate the relationship between INSTIs and metabolic adverse events using the FAERS database. METHODS: FAERS data were queried from quarter 4 of 2007 through quarter 4 of 2019 and limited to adults...
2023: Drugs in Context
https://read.qxmd.com/read/37521109/diagnosis-and-augmentation-therapy-for-alpha-1-antitrypsin-deficiency-current-knowledge-and-future-potential
#35
REVIEW
Paulo Henrique Feitosa
The underdiagnosis of alpha-1 antitrypsin (AAT) deficiency (AATD) has been recognized for many years, yet little progress has been made in treatment of the disease. In this review, we summarize the AATD disease process as well as its diagnosis and treatment by AAT augmentation therapy. AATD is a rare autosomal disease that primarily affects the lungs and liver. AATD is associated with an increased susceptibility to developing pulmonary emphysema. The specific pharmacological treatment for AATD is intravenous administration of exogenous AAT...
2023: Drugs in Context
https://read.qxmd.com/read/37521108/dietary-therapy-for-patients-with-chronic-pancreatitis-in-japan-a-cross-sectional-online-survey-of-physicians-and-registered-dietitians
#36
JOURNAL ARTICLE
Yuko Hasebe, Yusuke Karasawa, Kazutaka Nozawa
BACKGROUND: This study was aimed towards understanding the current status of dietary therapy for patients with pancreatic exocrine insufficiency (PEI) in Japan and its alignment with Japanese recommendations for high-fat intake and concomitant high-potency pancreatic enzyme replacement therapy (PERT) by surveying treating physicians and registered dietitians. METHODS: The 19-item physicians' online questionnaire collected data about the number of patients with PEI treated, methods used to assess PEI and nutritional status in patients with PEI, as well as provision of dietary guidance and details of treatment with PERT...
2023: Drugs in Context
https://read.qxmd.com/read/37521107/the-treatment-of-mild-upper-respiratory-tract-infections-a-position-paper-with-recommendations-for-best-practice
#37
REVIEW
Andrew Smith, Peter Kardos, Oliver Pfaar, Winfried Randerath, Guillermo Estrada Riolobos, Fulvio Braido, Laura Sadofsky
Following the waning severity of COVID-19 due to vaccination and the development of immunity, the current variants of SARS-CoV-2 often lead to mild upper respiratory tract infections (MURTIs), suggesting it is an appropriate time to review the pathogenesis and treatment of such illnesses. The present article reviews the diverse causes of MURTIs and the mechanisms leading to symptomatic illness. Different symptoms of MURTIs develop in a staggered manner and require targeted symptomatic treatment. A wide variety of remedies for home treatment is available, including over-the-counter drugs and plant-derived substances...
2023: Drugs in Context
https://read.qxmd.com/read/37415918/individuals-at-risk-for-severe-covid-19-in-whom-ritonavir-containing-therapies-are-contraindicated-or-may-lead-to-interactions-with-concomitant-medications-a-retrospective-analysis-of-german-health-insurance-claims-data
#38
REVIEW
Christoph Lübbert, Igor Dykukha, Jann-Patrick Pelz, Helen Yearley, Wolfgang Junker, Nina Gruber, Sibyll Escher, Katrin Biereth, Sima Melnik, Julia Puschmann
BACKGROUND: Nirmatrelvir/ritonavir is authorized for the treatment of COVID-19 but has several contraindications and potential drug-drug interactions (pDDIs) due to ritonavir-induced irreversible inhibition of cytochrome P450 3A4. We aimed to assess the prevalence of individuals with one or more risk factors for severe COVID-19 along with contraindications and pDDIs due to ritonavir-containing COVID-19 therapy. METHODS: Retrospective observational study of individuals with one or more risk factors according to Robert Koch Institute criteria for severe COVID-19 according to German statutory health insurance (SHI) claims data from the pre-pandemic years 2018-2019 based on the German Analysis Database for Evaluation and Health Services Research...
2023: Drugs in Context
https://read.qxmd.com/read/37415917/tinea-pedis-an-updated-review
#39
REVIEW
Alexander Kc Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong, Kam Lun Hon
BACKGROUND: Tinea pedis is one of the most common superficial fungal infections of the skin, with various clinical manifestations. This review aims to familiarize physicians with the clinical features, diagnosis and management of tinea pedis. METHODS: A search was conducted in April 2023 in PubMed Clinical Queries using the key terms 'tinea pedis' OR 'athlete's foot'. The search strategy included all clinical trials, observational studies and reviews published in English within the past 10 years...
2023: Drugs in Context
https://read.qxmd.com/read/37415916/real-world-management-of-abnormal-scarring-using-topical-silicone-gel-expert-consensus-and-case-series-from-the-asian-scars-expert-group
#40
Xiaonan Yang, Visnu Lohsiriwat, Frank Chun Shin Chang, Tan Thiam Chye, Catherine J Howard, Liang Qiao, Steven W Shaw, Tu Nguyen Anh Tran, Chan Yung, Daniel Dellosa, Dinesh Nagrale
Preventing abnormal scar formation and correcting non-aesthetic mature scars are important to prevent physical and psychosocial consequences of abnormal scarring. Evidence-based guidelines for scar management in Asian patients recommend first-line silicone-based products. Dermatix® * Ultra and Dermatix Ultra Kids are topical silicone gels containing a vitamin C ester that helps lighten scar tissue. Herein, we report a case series including patients with hypertrophic and keloid scars treated with Dermatix, showing that Dermatix is effective for scar treatment and prevention, as well as expert consensus supporting the safe and effective use of Dermatix...
2023: Drugs in Context
journal
journal
48111
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.